← back to search

Sandra Wagner Cardoso

Instituto Evandro Chagas · BR
Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV-related health complications and treatments, HIV Research and Treatment, and HIV/AIDS drug development and treatment.
h-index
34
citations
4,109
works
241
NIH funding
primary concept
Medicine
email

Recent publications

Association of long COVID with health-related quality-of-life outcomes
Scientific Reports 2026cited by 0position: middledoi
Deep Vein Thrombosis in Critically Ill Patients With COVID-19 Pneumonia: Incidence, Wells Score Diagnostic Performance, and Hospital Prognosis.
2026cited by 0position: contributordoi
Metabolic dysfunction-associated liver disease predicts incident liver fibrosis in people with HIV mono-infection: A cohort study.
2025cited by 1position: contributordoi
Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life.
2025cited by 1position: contributordoi
Deep vein thrombosis in critically ill patients with COVID-19: Incidence, Wells score diagnosis validation, and hospital prognosis
2025cited by 0position: contributordoi
Acceptability and usability of oral fluid HCV self-testing among health-facility users from Brazil: a cross-sectional study of 685 participants
The Brazilian Journal of Infectious Diseases 2025cited by 0position: contributordoi
Health economic outcomes of a minimal monitoring approach to providing HCV therapy.
2025cited by 0position: contributordoi
Platelet-neutrophil aggregate formation induces NLRP3 inflammasome activation in vaccine-induced thrombotic thrombocytopenia
Journal of Thrombosis and Haemostasis 2024cited by 6position: middledoi
Alignment of countries in the Americas with the latest WHO guidelines for hepatitis B virus (HBV) infection: a review
The Lancet Regional Health - Americas 2024cited by 4position: contributordoi
Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics
The Brazilian Journal of Infectious Diseases 2024cited by 4position: contributordoi
Frailty and health-related quality of life among older people living with HIV pre- and post-COVID-19 pandemic onset: A cross-sectional study
The Brazilian Journal of Infectious Diseases 2024cited by 3position: contributordoi
Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005.
2024cited by 0position: contributordoi
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Annals of Internal Medicine 2023cited by 63position: middledoi
Evaluation of Mpox Knowledge, Stigma, and Willingness to Vaccinate for Mpox: Cross-Sectional Web-Based Survey Among Sexual and Gender Minorities.
2023cited by 35position: contributordoi
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
2023cited by 32position: contributordoi
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Annals of Internal Medicine 2023cited by 31position: middledoi
Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil
The Brazilian Journal of Infectious Diseases 2023cited by 13position: contributordoi
Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis.
2023cited by 10position: contributordoi
The first case of acute HIV and monkeypox coinfection in Latin America
The Brazilian Journal of Infectious Diseases 2023cited by 9position: contributordoi
Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review.
2023cited by 7position: contributordoi
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.
2023cited by 6position: contributordoi
A Peer-Led Digital Intervention to Reduce HIV Prevention and Care Disparities Among Young Brazilian Transgender Women (The BeT Study): Protocol for an Intervention Study.
2023cited by 1position: contributordoi
SARS-CoV-2 transmission in a highly vulnerable population of Brazil: results from a household longitudinal study
2023cited by 0position: contributordoi
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
The Lancet Respiratory Medicine 2022cited by 55position: middledoi
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Nature Microbiology 2022cited by 53position: middledoi
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.
2022cited by 23position: contributordoi
Monkeypox and transgender women: The need for a global initiative.
2022cited by 10position: contributordoi
A Technology-Based Intervention Among Young Men Who Have Sex With Men and Nonbinary People (The Conectad@s Project): Protocol for A Vanguard Mixed Methods Study.
2022cited by 7position: contributordoi
Comparing Web-Based Venues to Recruit Gay, Bisexual, and Other Cisgender Men Who Have Sex With Men to a Large HIV Prevention Service in Brazil: Evaluation Study.
2022cited by 6position: contributordoi
Global Disparities in Skin Cancer Services at HIV Treatment Centers across 29 Countries.
2021cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2021–2026)Beatriz Grinsztejn · Instituto Nacional de Saúde17 papers (2022–2026)Valdilea G. Veloso · Demos13 papers (2022–2025)Thiago S Torres · Fundação Oswaldo Cruz10 papers (2022–2025)Emilia M. Jalil · Instituto Evandro Chagas8 papers (2022–2026) · 7 papers (2022–2026)Brenda Hoagland · INI Evandro Chagas/Fiocruz5 papers (2022–2023) · 5 papers (2024–2026)Hugo Perazzo · Apple (Israel)5 papers (2024–2026)Rita Estrela · Fundação Oswaldo Cruz4 papers (2023–2024)Ronaldo Ismerio Moreira · Fundação Oswaldo Cruz4 papers (2023–2026)Maria Pia Diniz Ribeiro · Instituto Evandro Chagas3 papers (2023–2026) · 3 papers (2022–2023)Laylla Monteiro · Instituto Evandro Chagas3 papers (2022–2023)Erin C. Wilson · University of California, San Francisco3 papers (2022–2023)HB Andrade · Universidade Federal do Rio de Janeiro2 papers (2025–2026)Laura M Smeaton · University of Aberdeen2 papers (2025–2025)Kim Mattos Geraldo · Fundação Oswaldo Cruz2 papers (2025–2026)Thainá Toledo · Fundação Oswaldo Cruz2 papers (2023–2024) · 2 papers (2023–2023)